Assignee
KANTUM PHARMA INC
US·0 granted patents·4 pending applications·0 citations·filing 2019–2020
Top patents by PatentIndex Score
4 records- 0146US2022202799A1Pharmaceutical formulations containing p2y14 antagonistsKANTUM PHARMA INC·Filed 2020·Application pending·0 cites
- 0236US2021113544A1Methods of monitoring, treating, and preventing renal inflammation associated with infectionKANTUM PHARMA INC·Filed 2019·Application pending·0 cites
- 0336US2021113543A1Methods of monitoring, treating, and preventing renal inflammation following cardiac procedures or eventsKANTUM PHARMA INC·Filed 2019·Application pending·0 cites
- 0436US2021121451A1Methods of monitoring, treating, and preventing renal inflammation associated with kidney transplantationKANTUM PHARMA INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KANTUM PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →